MedTrace Logo

Intradialytic Parenteral Nutrition in Hemodialysis Patients

NCT00501956 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2016-03-03

No results posted yet for this study

Summary

Malnutrition is a major cause of death in chronic hemodialysis patients. Primary treatment of malnutrition in these patients is dietetic counseling, additional enteral nutrition and occasionally drug therapy.

In cases where primary treatment of malnutrition is not effective, intradialytic parenteral nutrition (IDPN)during dialysis therapy may be administered. Using IDPN aminoacids, carbohydrates and fatty acids as well as vitamins and trace elements can be given to the patients.

Effectiveness of IDPN has to be verified.

Conditions

  • Malnutrition
  • Complication of Hemodialysis

Interventions

DRUG

Intradialytic Parenteral Nutrition (IDPN)

compounded IDPN, 3 x/week, 16 weeks intervention

Sponsors & Collaborators

  • Institute for Clinical Research

    collaborator OTHER

  • Fresenius Kabi

    lead INDUSTRY

Principal Investigators

  • Helmut Mann, Prof. Dr. · Interneph e.V, Aachen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00501956 on ClinicalTrials.gov